首页> 外文期刊>Endoscopy International Open >Use of over-the-scope clips (OTSC) for hemostasis in gastrointestinal bleeding in patients under antithrombotic therapy
【24h】

Use of over-the-scope clips (OTSC) for hemostasis in gastrointestinal bleeding in patients under antithrombotic therapy

机译:使用超广角夹子(OTSC)进行抗血栓治疗的患者胃肠道出血止血

获取原文
           

摘要

Background and study aims In patients taking different regimens of antithrombotic and/or anticoagulant therapy, endoscopic management of gastrointestinal bleeding represents a major challenge due to failing endogenous hemostasis. In this retrospective study we report on success rates with the over-the-scope clip (OTSC) system in upper and lower gastrointestinal bleeding in this high-risk patient population. Patients and methods Between February 2011 and June 2014, 75 patients were treated with an OTSC for active gastrointestinal bleeding. Success rates with the first endoscopic therapy, rebleeding episodes, their management and the influence of antithrombotic or anticoagulant therapy were analyzed retrospectively. Results Application of the OTSC resulted in immediate hemostasis (primary success rate) in all 75 patients. However, in 34.7?% a rebleeding episode was noted that could be treated by further endoscopic interventions. Only 3 patients had to be sent to the operating room because of failure of endoscopic therapy. In the rebleeding group the use of antiplatelet therapies was higher (73.1?% vs. 48.9?%). Conclusions Application of the OTSC in GI bleeding results in a high rate of primary hemostasis. Rebleeding occurs in up to 35?% of patients receiving antithrombotic/anticoagulant therapy but can be managed successfully with further endoscopic treatments. Patients in the rebleeding group were more frequently treated with antiplatelet agents. Radiological or surgical therapy was reserved for a small subgroup not successfully managed by repeated endoscopic therapies. OTSC application is the treatment of choice in high-risk patients when conventional clips used as first-line treatment fail. Comment to this article: Endoscopy International Open – recently published Endoscopy 2017; 49(06): 619-619DOI: 10.1055/s-0043-108846
机译:背景和研究目标在采用不同抗凝和/或抗凝治疗方案的患者中,由于内源性止血失败,内镜治疗胃肠道出血是一项重大挑战。在这项回顾性研究中,我们报告了在该高风险患者人群中,使用超范围夹(OTSC)系统治疗上消化道和下消化道出血的成功率。患者和方法2011年2月至2014年6月,有75例因活动性胃肠道出血而接受OTSC治疗。回顾性分析了首次内镜治疗的成功率,再出血事件,其管理以及抗血栓或抗凝治疗的影响。结果OTSC的使用可在所有75例患者中立即止血(主要成功率)。但是,在34.7%的患者中发现再出血事件可以通过进一步的内镜干预来治疗。由于内窥镜治疗失败,仅3名患者被送往手术室。在再出血组中,抗血小板治疗的使用率更高(分别为73.1%和48.9%)。结论OTSC在胃肠道出血中的应用可导致较高的原发止血率。在接受抗血栓/抗凝治疗的患者中,高达35%的患者发生再出血,但可以通过进一步的内镜治疗成功地再出血。再出血组的患者更常接受抗血小板药物治疗。放射疗法或外科手术疗法仅保留给一小部分亚组,这些亚组不能通过重复内镜治疗成功地进行治疗。当传统的夹子作为一线治疗失败时,OTSC应用是高危患者的首选治疗方法。对本文的评论:内窥镜国际公开赛–最近出版的《内窥镜检查2017》; 49(06):619-619DOI:10.1055 / s-0043-108846

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号